Spectral characterization of the benzoporphyrin derivative monoacid ring-A photoproduct formed in fetal calf solutions during irradiation with 694 nm continuous-wave radiation

Journal of Photochemistry and Photobiology B: Biology

Volumn 33, Issue 1, 1996, Pages 87-90

  Gillies, R ^a   Kollias, N ^a   Hasan, T ^a   Diddens, H ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b MEDICAL LASER CENTER LÜBECK   (Germany)

Author keywords

Benzoporphyrin derivative monoacid ring A; Photodynamic therapy; Photoproduct; Singlet oxygen; Spectroscopy

Indexed keywords

BENZOPORPHYRIN DERIVATIVE; PHOTOSENSITIZING AGENT;

ABSORPTION SPECTROSCOPY; ARTICLE; DRUG DEGRADATION; FETAL CALF SERUM; FLUORESCENCE SPECTROSCOPY; HUMAN; HUMAN CELL; LIGHT; PHOTODEGRADATION; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL;

ANIMALS; CATTLE; HUMANS; LASERS; PHOTOCHEMISTRY; PHOTOCHEMOTHERAPY; PORPHYRINS; RADIATION-SENSITIZING AGENTS; SPECTROMETRY, FLUORESCENCE; SPECTROPHOTOMETRY; TUMOR CELLS, CULTURED;

EID: 0029883431     PISSN: 10111344     EISSN: None     Source Type: Journal    
DOI: 10.1016/1011-1344(95)07222-5     Document Type: Article

References (17)

1. H. Lui, N. Kollias, J. Wimberly and R.R. Anderson, A preliminary report of cutaneous photosensitivity in patients undergoing photodynamic therapy with benzoporphyrin derivative-monoacid ring A, in P. Spinelli, M. Dalt Fante and R. Marchesini (eds.), Photodynamic Therapy and Biomedical Lasers, Elsevier, Amsterdam, 1992, pp. 459-460.
2. H. Lui, L. Hruza, N. Kollias, J. Wimberly, M. Gagel, D. McLean, V. Salvatori and R.R. Anderson, Photodynamic therapy of malignant skin tumors with benzoporphyrin derivative monoacid ring A (BPD-MA), Preliminary observations, SPIE Proc., 1876 (1993) 147-151.
3. L. Hruza, H. Lui, N. Kollias, J. Wimberly, P. Dwyer, M. Gagel, V. Salvatori and R.R. Anderson, Photodynamic therapy of psoriasis: preliminary evaluation of benzoporphyrin derivative monoacid ring A (BPD-MA), 21st Annu. Meet. of the American Society of Photobiology, Chicago, IL, 1993.
4. H.C. Neyndorff, D.L. Bartel, F. Tufaro and J.G. Levy, Development of a model to demonstrate photosensitizer-mediated viral inactivation in blood. Transfusion, 30 (1990) 485-490.
5. Y.N. Hsiang, M.T. Crespo, A.M. Richter, A.K. Jain, M. Fragoso and J.G. Levy, In-vitro and in-vivo uptake of benzoporphyrin derivative into human and miniswine atherosclerotic plaque, Photochem. Photobiol., 57 (1993) 670-674.
6. A.M. Richter, B. Kelly, J. Chow, D.J. Liu, G.H.N. Towers, D. Dolphin and J.G. Levy, Preliminary studies on a more effective phototoxic agent than hematoporphyrin, J. Natl. Cancer Inst., 79 (1987) 1327-1332.
7. B. Aveline, R.W. Redmond and T. Hasan, Photophysical and photosensitizing properties of benzoporphyrin derivative monoacid ring A (BPD-MA), Photochem. Photobiol., 59 (1994) 328-335.
8. A.M. Richter, S. Cerruti-Sola, E.D. Sternberg, D. Dolphin and J.G. Levy, Biodistribution of tritiated benzoporphyrin derivative (3H-BPD-MA), a new potent photosensitizer, in normal and tumor bearing mice, J. Photochem. Photobiol., B: Biol., 5 (1990) 231-244.
9. B.A. Allison, P.H. Pritchard, A.M. Richter and J.G. Levy, The plasma distribution of benzoporphyrin derivative and the effects of plasma lipoproteins on its biodistribution, Photochem. Photobiol., 52 (1990) 501-507.
10. B.E. Horsey and D.G. Whitten, Environmental effects on photochemical reactions: Contrasts in the photooxidation behavior of protoporphyrin IX in solution, monolayer films, organized monolayer assemblies and micelles, J. Am. Chem. Soc., 100 (1978) 1293-1295.
11. G.S. Cox and D.G. Whitten, Mechanism for the photooxidation of protoporphyrin IX in solution J. Am. Chem. Soc., 104 (1982) 516-521.
12. G.S. Cox, M. Krieg and D.G. Whitten, Self-sensitized photooxidation of protoporphyrin IX derivatives in aqueous surfactant solutions: product and mechanistic studies, J. Am. Chem. Soc., 104 (1982) 6930-6937.
13. G.S. Cox, C. Bobillier and D.G. Whitten, Photooxidation and singlet oxygen sensitization by protoporphyrin IX and its photooxidation products, Photochem. Photobiol., 36 (1982) 401-407.
14. M. Krieg and D.G. Whitten, Self-sensitized photooxidation of protoporphyrin IX and related free-based prophyrins in natural and model membrane systems. Evidence for novel photooxidation pathways involving amino acids, J. Am. Chem. Soc., 106 (1984) 2477-2479.
15. T.H. Foster, S.L. Gibson, L. Gao and R. Hilf, Analysis of photochemical oxygen consumption effects in photodynamic therapy, Optical Methods for Tumor Treatment and Detection, Proc. Soc. Photo.-Opt. Instrum. Eng., 1645 (1992) 104-114.
16. T.H. Foster, R.S. Murant, R.G. Bryant, R.S. Knox, S.L. Gibson and R. Hilf, Oxygen consumption and diffusion effects in photodynamic therapy, Radiat. Res., 126 (1991) 296-303.
17. V.H. Fingar, T.J. Wieman, Y.J. Park and B.W. Henderson, Implications of a pre-existing tumor hypoxic fraction on photodynamic therapy, J. Surg. Res., 53 (1992) 524-528.